Shock Synopsis February 2026. Shock. 2026; 65(2):119-122.
Novel murine partial tracheal occlusion model with altered respiratory dynamics. American Journal of Physiology - Lung Cellular and Molecular Physiology. 2025; 329(6):L749-L755.
Role of Extracellular Vesicles as Mediators of Cell Communication and Novel Biomarkers in Sepsis. Journal of Clinical Medicine. 2025; 14(18).
SHOCK SYNOPSIS MAY 2025. Shock. 2025; 63(5):665-667.
Derivation and Validation of a Clinical and Endothelial Biomarker Risk Model to Predict Persistent Pediatric Sepsis-Associated Acute Respiratory Dysfunction. CHEST Critical Care. 2025; 3(1).
SHOCK SYNOPSIS FEBRUARY 2025. Shock. 2025; 63(2):179-181.
KF4 Anti-Chymotrypsin-like Elastase 1 Antibody and Purified Alpha-1 Antitrypsin Have Similar but Not Additive Efficacy in Preventing Emphysema in Murine Alpha-1 Antitrypsin Deficiency. Chronic Obstructive Pulmonary Diseases. 2025; 12(1):12-22.
Neutrophil dysregulation differentiates pediatric septic shock biomarker-based mortality-risk strata: insights from weighted gene co-expression network and transcriptomic analyses. Frontiers in Immunology. 2025; 16:1663704.
SHOCK SYNOPSIS DECEMBER 2024. Shock. 2024; 62(6):737.
Humanin-G Ameliorates Hemorrhage-Induced Acute Lung Injury in Mice Through AMPKα1-Dependent and -Independent Mechanisms. Biomedicines. 2024; 12(11).
Diagnostic Validation of the Updated Pediatric Sepsis Biomarker Risk II for Acute Kidney Injury Prediction Model in Pediatric Septic Shock. Pediatric Critical Care Medicine. 2024; 25(11):1005-1016.
SHOCK SYNOPSIS AUGUST 2024. Shock. 2024; 62(4):459-460.
SHOCK SYNOPSIS OCTOBER 2024. Shock. 2024; 62(4):459-460.
SHOCK SYNOPSIS OCTOBER 2024. Shock. 2024; 62(4):459-460.
Identification and transcriptomic assessment of latent profile pediatric septic shock phenotypes. Critical Care. 2024; 28(1):246.
SHOCK SYNOPSIS MAY 2024. Shock. 2024; 61(5):647-649.
SHOCK SYNOPSIS MAY 2024. Shock. 2024; 61(5):647-649.
SHOCK SYNOPSIS MAY 2024. Shock. 2024; 61(5):647-649.
893: INDUCED PLURIPOTENT STEM CELL-DERIVED MONOCYTE RESPONSE TO RISK-STRATIFIED PEDIATRIC SEPTIC SERUM. Critical Care Medicine. 2024; 52(1):s419-s419.
SERUM HUMANIN IN PEDIATRIC SEPTIC SHOCK-ASSOCIATED MULTIPLE-ORGAN DYSFUNCTION SYNDROME. Shock. 2024; 61(1):83-88.
External validation of the modified sepsis renal angina index for prediction of severe acute kidney injury in children with septic shock. Critical Care. 2023; 27(1):463.
SERUM SOLUBLE ENDOGLIN IN PEDIATRIC SEPTIC SHOCK-ASSOCIATED MULTIPLE ORGAN DYSFUNCTION SYNDROME. Shock. 2023; 60(3):379-384.
PROTECTIVE EFFECTS OF HUMANIN-G IN HEMORRHAGIC SHOCK IN FEMALE MICE VIA AMPKα1-INDEPENDENT MECHANISMS. Shock. 2023; 60(1):64-74.
SEX-DEPENDENT EFFECTS OF ADIPOCYTE STAT3 INHIBITION ON THE INFLAMMATORY RESPONSE DURING SEVERE SEPSIS. Shock. 2023; 59(5):779-790.
Circulating extracellular vesicles are associated with the clinical outcomes of sepsis. Frontiers in Immunology. 2023; 14:1150564.
Expert consensus on the monitoring and treatment of sepsis-induced immunosuppression. Military Medical Research. 2022; 9(1):74.
Candidate Biomarkers for Sepsis-Associated Acute Kidney Injury Mechanistic Studies. Shock. 2022; 57(5):687-693.
Colivelin, a synthetic derivative of humanin, ameliorates endothelial injury and glycocalyx shedding after sepsis in mice. Frontiers in Immunology. 2022; 13:984298.